These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32472598)

  • 1. Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr
    Tengeler AC; Gart E; Wiesmann M; Arnoldussen IAC; van Duyvenvoorde W; Hoogstad M; Dederen PJ; Verweij V; Geenen B; Kozicz T; Kleemann R; Morrison MC; Kiliaan AJ
    FASEB J; 2020 Jul; 34(7):9575-9593. PubMed ID: 32472598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice.
    Jacobs SAH; Gart E; Vreeken D; Franx BAA; Wekking L; Verweij VGM; Worms N; Schoemaker MH; Gross G; Morrison MC; Kleemann R; Arnoldussen IAC; Kiliaan AJ
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
    Schoemaker MH; Kleemann R; Morrison MC; Verheij J; Salic K; van Tol EAF; Kooistra T; Wielinga PY
    PLoS One; 2017; 12(7):e0180648. PubMed ID: 28678821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis.
    Álvarez-Amor L; Sierra AL; Cárdenas A; López-Bermudo L; López-Beas J; Andújar E; Pérez-Alegre M; Gallego-Durán R; Varela LM; Martin-Montalvo A; Berná G; Rojas A; Robles-Frías MJ; Hmadcha A; Romero-Gómez M; Kleemann R; Martín F
    Sci Rep; 2021 Apr; 11(1):8250. PubMed ID: 33859314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat-Inactivated
    Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated weight cycling on non-alcoholic steatohepatitis in diet-induced obese mice.
    Inia JA; de Jong JCBC; Keijzer N; Menke AL; Princen HMG; Jukema JW; van den Hoek AM
    FASEB J; 2024 Apr; 38(7):e23579. PubMed ID: 38568838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice.
    Pelgrim CE; Franx BAA; Snabel J; Kleemann R; Arnoldussen IAC; Kiliaan AJ
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28686216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
    Mulder P; Morrison MC; Verschuren L; Liang W; van Bockel JH; Kooistra T; Wielinga PY; Kleemann R
    Sci Rep; 2016 Aug; 6():31542. PubMed ID: 27545964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice.
    Arnoldussen IAC; Wiesmann M; Pelgrim CE; Wielemaker EM; van Duyvenvoorde W; Amaral-Santos PL; Verschuren L; Keijser BJF; Heerschap A; Kleemann R; Wielinga PY; Kiliaan AJ
    Int J Obes (Lond); 2017 Jun; 41(6):935-944. PubMed ID: 28220041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.
    Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
    Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S
    Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytic Acid Improves Hepatic Steatosis, Inflammation, and Oxidative Stress in High-Fat Diet (HFD)-Fed Mice by Modulating the Gut-Liver Axis.
    Ran X; Hu G; He F; Li K; Li F; Xu D; Liu J; Fu S
    J Agric Food Chem; 2022 Sep; 70(36):11401-11411. PubMed ID: 36040330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.
    Morrison MC; Mulder P; Salic K; Verheij J; Liang W; van Duyvenvoorde W; Menke A; Kooistra T; Kleemann R; Wielinga PY
    Int J Obes (Lond); 2016 Sep; 40(9):1416-23. PubMed ID: 27121255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice.
    Salic K; Kleemann R; Wilkins-Port C; McNulty J; Verschuren L; Palmer M
    PLoS One; 2019; 14(6):e0218459. PubMed ID: 31233523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
    Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
    Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine.
    Mueller AM; Kleemann R; Gart E; van Duyvenvoorde W; Verschuren L; Caspers M; Menke A; Krömmelbein N; Salic K; Burmeister Y; Seilheimer B; Morrison MC
    Front Endocrinol (Lausanne); 2021; 12():601160. PubMed ID: 33815271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.
    van den Hoek AM; de Jong JCBC; Worms N; van Nieuwkoop A; Voskuilen M; Menke AL; Lek S; Caspers MPM; Verschuren L; Kleemann R
    Metabolism; 2021 Nov; 124():154873. PubMed ID: 34478753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
    Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
    J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.